DXR
Daxor Corp.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
Actual EPS |
---|
Consensus EPS |
Estimated EPS |
Number of Estimates |
EPS Surprise |
Stats
Summary
the bva-100 (blood volume analyzer) is the first instrument of its kind that can precisely measure the amount of blood a patient has in their body. blood volume measurements have been available for almost 60 years, but the test often took 4 to 8 hours to perform and was very difficult to perform accurately. due to these issues, blood volume measurements were very rarely done. physicians had been forced to rely on substitute tests that were only able to measure the thickness of the blood and can be very misleading in many surgical and medical situations. the bva-100 can measure blood volume: accurately, quickly & reliably.
Market Cap: 35.5 Million
Primary Exchange: NASDAQ
Website: daxor.com
Shares Outstanding: 4.73 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.0
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Ethical Flags
Longest drawdown: 1169 trading days
From: 2020-07-17 To: 2024-03-07
Lowest Point:
Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
---|---|---|---|---|---|---|---|---|
2018-01-05 | 2018-01-12 | 2018-01-08 | 2017-12-28 | 0.03 | No Change QoQ | |||
2016-12-20 | 2016-12-29 | 2016-12-22 | 2016-11-18 | 0.03 | Decrease | |||
2015-12-18 | 2015-12-29 | 2015-12-22 | 2015-12-10 | 0.04 | Increase | |||
2014-12-04 | 2014-12-26 | 2014-12-08 | 2014-11-17 | 0.03 | Decrease | |||
2018-01-05 | 2018-01-12 | 2018-01-08 | 2017-12-21 | 0.029999999329447746 | Cash |
Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
---|